{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:27:59Z","timestamp":1791037679153,"version":"4.1.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73105-4","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T12:01:50Z","timestamp":1727524910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A multi-epitope protein vaccine encapsulated in alginate nanoparticles as a candidate vaccine against Shigella sonnei"],"prefix":"10.1038","volume":"14","author":[{"given":"Parisa","family":"Hashemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Osanloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar","family":"Farjadfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Nasiri-Ghiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Zarenezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9263-8236","authenticated-orcid":false,"given":"Shirin","family":"Mahmoodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"73105_CR1","doi-asserted-by":"crossref","unstructured":"Schnupf, P. & Sansonetti, P. J. Shigella pathogenesis: New insights through advanced methodologies. Bacteria Intracell.1,15\u201339 (2019).","DOI":"10.1128\/9781683670261.ch2"},{"issue":"11","key":"73105_CR2","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S1473-3099(18)30362-1","volume":"18","author":"C Troeger","year":"2018","unstructured":"Troeger, C. et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: A systematic analysis for the global burden of disease study 2016. Lancet. Infect. Dis. 18 (11), 1211\u20131228 (2018).","journal-title":"Lancet. Infect. Dis"},{"issue":"1","key":"73105_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/lam.12690","volume":"64","author":"D Muthuirulandi Sethuvel","year":"2017","unstructured":"Muthuirulandi Sethuvel, D., Devanga Ragupathi, N., Anandan, S. & Veeraraghavan, B. Update on: Shigella new serogroups\/serotypes and their antimicrobial resistance. Lett. Appl. Microbiol.64 (1), 8\u201318 (2017).","journal-title":"Lett. Appl. Microbiol."},{"key":"73105_CR4","unstructured":"Halimeh, F. B. et al. Historical, current, and emerging tools for identification and serotyping of Shigella. Braz. J. Microbiol.\u00a05,1\u201313. (2021)."},{"issue":"1","key":"73105_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40348-022-00145-z","volume":"9","author":"A Nasser","year":"2022","unstructured":"Nasser, A., Mosadegh, M., Azimi, T. & Shariati, A. Molecular mechanisms of Shigella effector proteins: A common pathogen among diarrheic pediatric population. Mol. Cell. Pediatr.9(1), 12 (2022).","journal-title":"Mol. Cell. Pediatr."},{"key":"73105_CR6","doi-asserted-by":"publisher","first-page":"249163","DOI":"10.3389\/fcimb.2017.00064","volume":"7","author":"E Mattock","year":"2017","unstructured":"Mattock, E. & Blocker, A. J. How do the virulence factors of Shigella work together to cause disease?. Front. Cell. Infect. Microbiol.7, 249163 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"12","key":"73105_CR7","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.3390\/microorganisms8121933","volume":"8","author":"W Bajunaid","year":"2020","unstructured":"Bajunaid, W. et al. The T3SS of Shigella: Expression, structure, function, and role in vacuole escape. Microorganisms8(12), 1933 (2020).","journal-title":"Microorganisms"},{"key":"73105_CR8","doi-asserted-by":"crossref","unstructured":"Bennish, M. L. & Ahmed, S. Shigellosis. Hunter\u2019s Tropical Medicine and Emerging Infectious Diseases. 492\u2013499 (Elsevier, 2020).","DOI":"10.1016\/B978-0-323-55512-8.00048-X"},{"issue":"2","key":"73105_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/microorganisms9020451","volume":"9","author":"M Muthuramalingam","year":"2021","unstructured":"Muthuramalingam, M., Whittier, S. K., Picking, W. L. & Picking, W. D. The Shigella type III secretion system: An overview from top to bottom. Microorganisms.  9 (2), 451 (2021).","journal-title":"Microorganisms"},{"key":"73105_CR10","doi-asserted-by":"crossref","unstructured":"Ali Nor, B. S., Menza, N. C. & Musyoki, A. M. Multidrug-resistant shigellosis among children aged below five years with diarrhea at Banadir hospital in Mogadishu, Somalia. Can.  J.  Infect.  Dis. Med. Microbiol.  2021. (2021).","DOI":"10.1155\/2021\/6630272"},{"key":"73105_CR11","doi-asserted-by":"crossref","unstructured":"Assefa, A. & Girma, M. Prevalence and antimicrobial susceptibility patterns of Salmonella and Shigella isolates among children aged below five years with diarrhea attending Robe General Hospital and Goba Referral Hospital, South East Ethiopia. Trop. Dis.  Travel Med.  Vac. 5(1), 19 (2019).","DOI":"10.1186\/s40794-019-0096-6"},{"issue":"13","key":"73105_CR12","first-page":"e3293","volume":"9","author":"A Sharma","year":"2019","unstructured":"Sharma, A. & Puhar, A. Plaque assay to determine invasion and intercellular dissemination of Shigella flexneri in TC7 human intestinal epithelial cells. Bio-protocol.  9 (13), e3293\u2013e (2019).","journal-title":"Bio-protocol"},{"issue":"10122","key":"73105_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0140-6736(17)33296-8","volume":"391","author":"KL Kotloff","year":"2018","unstructured":"Kotloff, K. L., Riddle, M. S., Platts-Mills, J. A., Pavlinac, P. & Zaidi, A. K. Shigellosis Lancet391(10122), 801\u2013812 (2018).","journal-title":"Shigellosis Lancet"},{"issue":"9","key":"73105_CR14","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1021\/acs.jmedchem.1c00152","volume":"64","author":"D Haksar","year":"2021","unstructured":"Haksar, D. et al. Fighting shigella by blocking its disease-causing toxin. J. Med. Chem.64(9), 6059\u20136069 (2021).","journal-title":"J. Med. Chem."},{"issue":"4","key":"73105_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jiph.2017.09.025","volume":"11","author":"M Puzari","year":"2018","unstructured":"Puzari, M., Sharma, M. & Chetia, P. Emergence of antibiotic resistant Shigella species: A matter of concern. J. Infect. Public Health. 11 (4), 451\u2013454 (2018).","journal-title":"J. Infect. Public Health"},{"issue":"11","key":"73105_CR16","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3390\/antibiotics11111653","volume":"11","author":"MZ Salleh","year":"2022","unstructured":"Salleh, M. Z. et al. Prevalence of multidrug-resistant and extended-spectrum beta-lactamase-producing Shigella species in Asia: A systematic review and meta-analysis. Antibiotics. 11 (11), 1653 (2022).","journal-title":"Antibiotics"},{"key":"73105_CR17","doi-asserted-by":"crossref","unstructured":"Ranjbar, R. & Farahani, A. Shigella: Antibiotic-resistance mechanisms and new horizons for treatment. Infect. Drug Resist. 3137\u20133167 (2019).","DOI":"10.2147\/IDR.S219755"},{"issue":"7","key":"73105_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1128\/CVI.00665-15","volume":"23","author":"P Pitisuttithum","year":"2016","unstructured":"Pitisuttithum, P. et al. Clinical trial of an oral live shigella sonnei vaccine candidate, wrss1, in Thai adults. Clin. Vaccine Immunol.23(7), 564\u2013575 (2016).","journal-title":"Clin. Vaccine Immunol."},{"issue":"4","key":"73105_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1128\/CVI.00608-15","volume":"23","author":"S Chakraborty","year":"2016","unstructured":"Chakraborty, S. et al. Evaluation of the safety, tolerability, and immunogenicity of an oral, inactivated whole-cell Shigella flexneri 2a vaccine in healthy adult subjects. Clin. Vaccine Immunol.23(4), 315\u2013325 (2016).","journal-title":"Clin. Vaccine Immunol."},{"key":"73105_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10989-018-9698-5","volume":"25","author":"I Farhani","year":"2019","unstructured":"Farhani, I., Nezafat, N. & Mahmoodi, S. Designing a novel multi-epitope peptide vaccine against pathogenic Shigella spp. based immunoinformatics approaches. Int. J. Pept. Res. Ther.25, 541\u2013553 (2019).","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"10","key":"73105_CR21","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.cmi.2018.06.023","volume":"24","author":"M Riddle","year":"2018","unstructured":"Riddle, M., Chen, W., Kirkwood, C. & MacLennan, C. Update on vaccines for enteric pathogens. Clin. Microbiol. Infect.24(10), 1039\u20131045 (2018).","journal-title":"Clin. Microbiol. Infect."},{"issue":"28","key":"73105_CR22","first-page":"219","volume":"96","author":"WH Organization","year":"2021","unstructured":"Organization, W. H. Rotavirus vaccines: WHO position paper\u2013July 2021. Wkly. Epidemiol. Rec. 96 (28), 219\u2013301 (2021).","journal-title":"Wkly. Epidemiol. Rec"},{"key":"73105_CR23","first-page":"129","volume":"924","author":"Organization WH","year":"2004","unstructured":"Organization WH. Guidelines for the production and control of inactivated oral cholera vaccines. WHO Tech. Rep. Ser.924, 129\u2013149 (2004).","journal-title":"WHO Tech. Rep. Ser."},{"key":"73105_CR24","doi-asserted-by":"crossref","unstructured":"Pasetti, M. F., Venkatesan, M. M. & Barry, E. M. Oral Shigella vaccines. Mucosal Vaccines 515\u2009\u2013\u2009356. (2020).","DOI":"10.1016\/B978-0-12-811924-2.00030-4"},{"issue":"4","key":"73105_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/17425247.2020.1731468","volume":"17","author":"M Skwarczynski","year":"2020","unstructured":"Skwarczynski, M. & Toth, I. Non-invasive mucosal vaccine delivery: Advantages, challenges and the future. Expert Opin. Drug Deliv.17(4), 435\u2013437 (2020).","journal-title":"Expert Opin. Drug Deliv."},{"issue":"7","key":"73105_CR26","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s13238-015-0164-2","volume":"6","author":"S Wang","year":"2015","unstructured":"Wang, S., Liu, H., Zhang, X. & Qian, F. Intranasal and oral vaccination with protein-based antigens: Advantages, challenges and formulation strategies. Protein Cell6(7), 480\u2013503 (2015).","journal-title":"Protein Cell"},{"key":"73105_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.addr.2015.03.007","volume":"91","author":"CJ Davitt","year":"2015","unstructured":"Davitt, C. J. & Lavelle, E. C. Delivery strategies to enhance oral vaccination against enteric infections. Adv. Drug Deliv. Rev.91, 52\u201369 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"73105_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12951-023-01780-y","volume":"21","author":"N Baruah","year":"2023","unstructured":"Baruah, N., Ahamad, N., Halder, P., Koley, H. & Katti, D. S. Facile synthesis of multi-faceted, biomimetic and cross-protective nanoparticle-based vaccines for drug-resistant Shigella: A flexible platform technology. J. Nanobiotechnol.21(1), 34 (2023).","journal-title":"J. Nanobiotechnol."},{"key":"73105_CR29","doi-asserted-by":"publisher","first-page":"115813","DOI":"10.1016\/j.carbpol.2019.115813","volume":"232","author":"F Gilavand","year":"2020","unstructured":"Gilavand, F., Marzban, A., Ebrahimipour, G., Soleimani, N. & Goudarzi, M. Designation of chitosan nano-vaccine based on MxiH antigen of Shigella flexneri with increased immunization capacity. Carbohydr. Polym.232, 115813 (2020).","journal-title":"Carbohydr. Polym."},{"issue":"32","key":"73105_CR30","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1016\/j.vaccine.2013.05.020","volume":"31","author":"A Camacho","year":"2013","unstructured":"Camacho, A., Irache, J., De Souza, J., S\u00e1nchez-G\u00f3mez, S. & Gamazo, C. Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice. Vaccine. 31 (32), 3288\u20133294 (2013).","journal-title":"Vaccine"},{"issue":"1","key":"73105_CR31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12906-023-04266-4","volume":"23","author":"M Osanloo","year":"2023","unstructured":"Osanloo, M. et al. Comparison effects of Ferula gummosa essential oil and Beta-pinene Alginate nanoparticles on human melanoma and breast cancer cells proliferation and apoptotic index in short term normobaric hyperoxic model. BMC Complement. Med. Ther.23(1), 428 (2023).","journal-title":"BMC Complement. Med. Ther."},{"key":"73105_CR32","doi-asserted-by":"publisher","first-page":"S319","DOI":"10.33549\/physiolres.933980","volume":"67","author":"E Wawrzy\u0144ska","year":"2018","unstructured":"Wawrzy\u0144ska, E. & Kubies, D. Alginate matrices for protein delivery\u2013A short review. Physiol. Res.67, S319\u2013S34 (2018).","journal-title":"Physiol. Res."},{"issue":"2","key":"73105_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1773-2247(14)50029-9","volume":"24","author":"D Hariyadi","year":"2014","unstructured":"Hariyadi, D. et al. The potential for production of freeze-dried oral vaccines using alginate hydrogel microspheres as protein carriers. J. Drug Deliv. Sci. Technol.24(2), 178\u2013184 (2014).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"73105_CR34","doi-asserted-by":"crossref","unstructured":"Yang, D. & Jones, K. S. Effect of alginate on innate immune activation of macrophages. J.  Biomed. Mater.  Res.  Part A\u00a090(2), 411\u2013418 (2009).","DOI":"10.1002\/jbm.a.32096"},{"issue":"4","key":"73105_CR35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.4103\/0250-474X.119829","volume":"75","author":"F Sarei","year":"2013","unstructured":"Sarei, F., Dounighi, N. M., Zolfagharian, H., Khaki, P. & Bidhendi, S. M. Alginate nanoparticles as a promising adjuvant and vaccine delivery system. Indian J. Pharm. Sci.75 (4), 442 (2013).","journal-title":"Indian J. Pharm. Sci."},{"issue":"A","key":"73105_CR36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3889\/oamjms.2020.4930","volume":"8","author":"E Bakhrushina","year":"2020","unstructured":"Bakhrushina, E. et al. Comparative study of the mucoadhesive properties of polymers for pharmaceutical use. Open. Access. Macedonian J. Med. Sci.8 (A), 639\u2013645 (2020).","journal-title":"Open. Access. Macedonian J. Med. Sci."},{"issue":"1","key":"73105_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0939-6411(97)00102-1","volume":"44","author":"DQ Craig","year":"1997","unstructured":"Craig, D. Q. & Tamburic, S. Dielectric analysis of bioadhesive gel systems. Eur. J. Pharm. Biopharm.44 (1), 61\u201370 (1997).","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"73105_CR38","first-page":"8886095","volume":"2020","author":"DM Hariyadi","year":"2020","unstructured":"Hariyadi, D. M. & Islam, N. Current status of alginate in drug delivery. Adv. Pharmacol. Pharm. Sci.2020 (1), 8886095 (2020).","journal-title":"Adv. Pharmacol. Pharm. Sci."},{"key":"73105_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13036-019-0223-y","volume":"14","author":"F Abasalizadeh","year":"2020","unstructured":"Abasalizadeh, F. et al. Alginate-based hydrogels as drug delivery vehicles in cancer treatment and their applications in wound dressing and 3D bioprinting. J. Biol. Eng.14, 1\u201322 (2020).","journal-title":"J. Biol. Eng."},{"issue":"3","key":"73105_CR40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/pharmaceutics16030370","volume":"16","author":"J Lai","year":"2024","unstructured":"Lai, J. et al. Alginate-based encapsulation fabrication technique for drug delivery: An updated review of particle type, formulation technique, pharmaceutical ingredient, and targeted delivery system. Pharmaceutics. 16 (3), 370 (2024).","journal-title":"Pharmaceutics"},{"key":"73105_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.meegid.2017.12.008","volume":"58","author":"M Negahdaripour","year":"2018","unstructured":"Negahdaripour, M. et al. Structural vaccinology considerations for in silico designing of a multi-epitope vaccine. Infect. Genet. Evol.58, 96\u2013109 (2018).","journal-title":"Infect. Genet. Evol."},{"issue":"2","key":"73105_CR42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/cmi.2017.92","volume":"15","author":"L Zhang","year":"2018","unstructured":"Zhang, L. Multi-epitope vaccines: A promising strategy against tumors and viral infections. Cell Mol. Immunol.15 (2), 182\u2013184 (2018).","journal-title":"Cell Mol. Immunol."},{"issue":"11","key":"73105_CR43","doi-asserted-by":"publisher","first-page":"e0289773","DOI":"10.1371\/journal.pone.0289773","volume":"18","author":"S Aiman","year":"2023","unstructured":"Aiman, S. et al. Vaccinomics-aided next-generation novel multi-epitope-based vaccine engineering against multidrug resistant Shigella Sonnei: Immunoinformatics and chemoinformatics approaches. Plos One. 18 (11), e0289773 (2023).","journal-title":"Plos One"},{"key":"73105_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.molimm.2019.09.018","volume":"116","author":"M Nosrati","year":"2019","unstructured":"Nosrati, M. et al. Designing a multi-epitope vaccine for cross-protection against Shigella spp: An immunoinformatics and structural vaccinology study. Mol. Immunol.116, 106\u2013116 (2019).","journal-title":"Mol. Immunol."},{"key":"73105_CR45","doi-asserted-by":"crossref","unstructured":"Akhgar, S. et al. Immunization of BALB\/c mice against Shigella sonnei using a multiepitope protein vaccine through intranasal and subcutaneous administration. Iran. J. Allergy Asthma Immunol. 1\u201310 (2024).","DOI":"10.18502\/ijaai.v23i4.16215"},{"key":"73105_CR46","first-page":"22","volume":"1","author":"AY Chang","year":"2017","unstructured":"Chang, A. Y., Chau, V., Landas, J. A. & Pang, Y. Preparation of calcium competent Escherichia coli and heat-shock transformation. JEMI Methods.  1, 22\u201325 (2017).","journal-title":"JEMI Methods"},{"issue":"1","key":"73105_CR47","doi-asserted-by":"publisher","first-page":"A3M1","DOI":"10.1002\/9780471729259.mca03ms22","volume":"22","author":"JM Manns","year":"2011","unstructured":"Manns, J.M. SDS-polyacrylamide gel electrophoresis (SDS\u2010PAGE) of proteins. Curr. Protoc. Microbiol.22 (1), A3M1\u2013A3M13 (2011).","journal-title":"Curr. Protoc. Microbiol."},{"issue":"1\u20132","key":"73105_CR48","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem.72 (1\u20132), 248\u2013254 (1976).","journal-title":"Anal. Biochem."},{"issue":"2","key":"73105_CR49","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s00289-023-04797-3","volume":"81","author":"A Valizadeh","year":"2024","unstructured":"Valizadeh, A. et al. Alginate nanoparticles containing Lavandula angustifolia essential oil as a potential potent, biocompatible and low-cost antitumor agent. Polym. Bull.81 (2), 1861\u20131874 (2024).","journal-title":"Polym. Bull."},{"key":"73105_CR50","doi-asserted-by":"crossref","unstructured":"Yarian, F. et al. Comparison effects of alginate nanoparticles containing Syzygium aromaticum essential oil and eugenol on apoptotic regulator genes and viability of A-375 and MCF-7 cancer cell lines. BioNanoScience (2023).","DOI":"10.1007\/s12668-023-01121-1"},{"issue":"1","key":"73105_CR51","doi-asserted-by":"publisher","first-page":"12115","DOI":"10.1038\/s41598-023-39402-0","volume":"13","author":"K Tabynov","year":"2023","unstructured":"Tabynov, K. et al. An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters. Sci. Rep.13 (1), 12115 (2023).","journal-title":"Sci. Rep."},{"issue":"4","key":"73105_CR52","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/vaccines8040563","volume":"8","author":"Y Le\u00f3n","year":"2020","unstructured":"Le\u00f3n, Y. et al. Intranasal immunization of mice with multiepitope chimeric vaccine candidate based on conserved autotransporters SigA, Pic and Sap, confers protection against Shigella flexneri. Vaccines. 8 (4), 563 (2020).","journal-title":"Vaccines"},{"issue":"44","key":"73105_CR53","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1016\/j.vaccine.2016.08.034","volume":"34","author":"S Chitradevi","year":"2016","unstructured":"Chitradevi, S., Kaur, G., Sivaramakrishna, U., Singh, D. & Bansal, A. Development of recombinant vaccine candidate molecule against Shigella infection. Vaccine. 34 (44), 5376\u20135383 (2016).","journal-title":"Vaccine"},{"key":"73105_CR54","unstructured":"Pavia, D. L., Lampman, G. M., Kriz, G. S. & Vyvyan, J. R. Introduction to Spectroscopy. (2015)."},{"key":"73105_CR55","unstructured":"Najwa, M. H. & Solehah, N. N. (eds) Encapsulation of protein within alginate-inulin matrix for targeted drug delivery system. J.  Phys.  Conf.  Ser.  (IOP Publishing) (2020)."},{"issue":"6","key":"73105_CR56","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1002\/fsn3.3261","volume":"11","author":"M Osanloo","year":"2023","unstructured":"Osanloo, M., Eskandari, Z., Zarenezhad, E., Qasemi, H. & Nematollahi, A. Studying the microbial, chemical, and sensory characteristics of shrimp coated with alginate sodium nanoparticles containing Zataria multiflora and Cuminum cyminum essential oils. Food Sci. Nutr.11 (6), 2823\u20132837 (2023).","journal-title":"Food Sci. Nutr."},{"issue":"3","key":"73105_CR57","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s12668-023-01121-1","volume":"13","author":"F Yarian","year":"2023","unstructured":"Yarian, F. et al. Comparison effects of alginate nanoparticles containing syzygium aromaticum essential oil and eugenol on apoptotic regulator genes and viability of A-375 and MCF-7 cancer cell lines. BioNanoScience. 13 (3), 911\u2013919 (2023).","journal-title":"BioNanoScience"},{"issue":"2","key":"73105_CR58","first-page":"139","volume":"68","author":"S Moradi Bidhendi","year":"2013","unstructured":"Moradi Bidhendi, S. et al. Design and evaluate alginate nanoparticles as a protein delivery system. Arch. Razi Inst.68 (2), 139\u2013146 (2013).","journal-title":"Arch. Razi Inst."},{"issue":"3","key":"73105_CR59","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1081\/PDT-100002247","volume":"6","author":"A Mitrevej","year":"2001","unstructured":"Mitrevej, A., Sinchaipanid, N., Rungvejhavuttivittaya, Y. & Kositchaiyong, V. Multiunit controlled-release diclofenac sodium capsules using complex of chitosan with sodium alginate or pectin. Pharm. Dev. Technol.6 (3), 385\u2013392 (2001).","journal-title":"Pharm. Dev. Technol."},{"key":"73105_CR60","unstructured":"Aslam, A. & Okafor, C. N.  Shigella StatPearls [Internet] (StatPearls Publishing, 2022)."},{"key":"73105_CR61","doi-asserted-by":"crossref","unstructured":"Holmgren, J. & Lundgren, A. Diarrhea Caused by Bacteria. 252\u2013260.e4 (Elsevier, 2018).","DOI":"10.1016\/B978-0-323-35761-6.00018-3"},{"issue":"5","key":"73105_CR62","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2174\/1570164617666190919120140","volume":"17","author":"MM Goumari","year":"2020","unstructured":"Goumari, M. M., Farhani, I., Nezafat, N. & Mahmoodi, S. Multi-epitope vaccines (MEVs), as a novel strategy against infectious diseases. Curr. Proteom.  17 (5), 354\u2013364 (2020).","journal-title":"Curr. Proteom."},{"issue":"3","key":"73105_CR63","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/pathogens12030376","volume":"12","author":"SR Mahapatra","year":"2023","unstructured":"Mahapatra, S. R., Dey, J., Raj, T. K., Misra, N. & Suar, M. Designing a next-generation multiepitope-based vaccine against Staphylococcus aureus using reverse vaccinology approaches. Pathogens. 12 (3), 376 (2023).","journal-title":"Pathogens"},{"key":"73105_CR64","doi-asserted-by":"publisher","first-page":"104970","DOI":"10.1016\/j.micpath.2021.104970","volume":"157","author":"E Jafari","year":"2021","unstructured":"Jafari, E. & Mahmoodi, S. Design, expression, and purification of a multi-epitope vaccine against Helicobacter Pylori based on Melittin as an adjuvant. Microb. Pathog.157, 104970 (2021).","journal-title":"Microb. Pathog."},{"issue":"2","key":"73105_CR65","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00251-022-01282-5","volume":"75","author":"EK Oladipo","year":"2023","unstructured":"Oladipo, E. K. et al. Bioinformatics analysis of structural protein to approach a vaccine candidate against Vibrio cholerae infection. Immunogenetics.  75 (2), 99\u2013114 (2023).","journal-title":"Immunogenetics"},{"issue":"1","key":"73105_CR66","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12859-023-05183-6","volume":"24","author":"B Beikzadeh","year":"2023","unstructured":"Beikzadeh, B. Immunoinformatics design of multi-epitope vaccine using OmpA, OmpD and enterotoxin against non-typhoidal salmonellosis. BMC Bioinform.24 (1), 63 (2023).","journal-title":"BMC Bioinform."},{"issue":"3","key":"73105_CR67","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/v14030520","volume":"14","author":"F Feng","year":"2022","unstructured":"Feng, F. et al. Strategies to develop a mucosa-targeting vaccine against emerging infectious diseases. Viruses. 14 (3), 520 (2022).","journal-title":"Viruses"},{"issue":"1","key":"73105_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41541-023-00797-6","volume":"9","author":"G Desalegn","year":"2024","unstructured":"Desalegn, G. et al. Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate. npj Vaccines. 9 (1), 2 (2024).","journal-title":"npj Vaccines"},{"key":"73105_CR69","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.imlet.2019.10.013","volume":"217","author":"M Li","year":"2020","unstructured":"Li, M. et al. Mucosal vaccines: strategies and challenges. Immunol. Lett.217, 116\u2013125 (2020).","journal-title":"Immunol. Lett."},{"key":"73105_CR70","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.addr.2017.04.008","volume":"114","author":"JEV Ramirez","year":"2017","unstructured":"Ramirez, J. E. V., Sharpe, L. A. & Peppas, N. A. Current state and challenges in developing oral vaccines. Adv. Drug Deliv. Rev.114, 116\u2013131 (2017).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"73105_CR71","doi-asserted-by":"publisher","first-page":"682286","DOI":"10.3389\/fphar.2021.682286","volume":"12","author":"SD Jazayeri","year":"2021","unstructured":"Jazayeri, S. D., Lim, H. X., Shameli, K., Yeap, S. K. & Poh, C. L. Nano and microparticles as potential oral vaccine carriers and adjuvants against infectious diseases. Front. Pharmacol.12, 682286 (2021).","journal-title":"Front. Pharmacol."},{"key":"73105_CR72","doi-asserted-by":"publisher","first-page":"385476","DOI":"10.3389\/fimmu.2018.02224","volume":"9","author":"R Pati","year":"2018","unstructured":"Pati, R., Shevtsov, M. & Sonawane, A. Nanoparticle vaccines against infectious diseases. Front. Immunol.9, 385476 (2018).","journal-title":"Front. Immunol."},{"key":"73105_CR73","doi-asserted-by":"crossref","unstructured":"Karandikar, S., Mirani, A., Waybhase, V., Patravale, V. B. & Patankar, S. Nanovaccines for Oral Delivery-Formulation Strategies and Challenges. 263\u2013293 (Elsevier, 2017).","DOI":"10.1016\/B978-0-323-47720-8.00011-0"},{"key":"73105_CR74","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijbiomac.2017.12.137","volume":"111","author":"Y Shtenberg","year":"2018","unstructured":"Shtenberg, Y. et al. Mucoadhesive alginate pastes with embedded liposomes for local oral drug delivery. Int. J. Biol. Macromol.111, 62\u201369 (2018).","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"73105_CR75","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/jcp.1041520225","volume":"152","author":"EC Downs","year":"1992","unstructured":"Downs, E. C., Robertson, N. E., Riss, T. L. & Plunkett, M. L. Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro. J. Cell. Physiol.152 (2), 422\u2013429 (1992).","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"73105_CR76","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.foodhyd.2009.10.007","volume":"25","author":"KI Draget","year":"2011","unstructured":"Draget, K. I. & Taylor, C. Chemical, physical and biological properties of alginates and their biomedical implications. Food Hydrocoll.25 (2), 251\u2013256 (2011).","journal-title":"Food Hydrocoll."},{"key":"73105_CR77","doi-asserted-by":"publisher","first-page":"123770","DOI":"10.1016\/j.ijbiomac.2023.123770","volume":"235","author":"C Zhu","year":"2023","unstructured":"Zhu, C. et al. Characterization and evaluation of an oral vaccine via nano-carrier for surface immunogenic protein (sip) delivery against Streptococcus agalactiae infection. Int. J. Biol. Macromol.235, 123770 (2023).","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"73105_CR78","doi-asserted-by":"publisher","first-page":"e1894","DOI":"10.1371\/journal.pntd.0001894","volume":"6","author":"CR Oliveira","year":"2012","unstructured":"Oliveira, C. R. et al. A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasis. PLoS Negl. Trop. Dis.6 (11), e1894 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"73105_CR79","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.actbio.2018.09.037","volume":"80","author":"RJ Nevagi","year":"2018","unstructured":"Nevagi, R. J. et al. Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group a streptococcus. Acta Biomater.80, 278\u2013287 (2018).","journal-title":"Acta Biomater."},{"issue":"8","key":"73105_CR80","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/vaccines10081180","volume":"10","author":"A Pumchan","year":"2022","unstructured":"Pumchan, A. et al. A novel efficient piscine oral nano-vaccine delivery system: modified halloysite nanotubes (HNTs) preventing streptococcosis disease in tilapia (Oreochromis Sp). Vaccines. 10 (8), 1180 (2022).","journal-title":"Vaccines"},{"key":"73105_CR81","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.biomaterials.2015.04.017","volume":"59","author":"B Singh","year":"2015","unstructured":"Singh, B. et al. Attuning hydroxypropyl methylcellulose phthalate to oral delivery vehicle for effective and selective delivery of protein vaccine in ileum. Biomaterials. 59, 144\u2013159 (2015).","journal-title":"Biomaterials"},{"issue":"1","key":"73105_CR82","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsps.2017.10.012","volume":"26","author":"SA Rizvi","year":"2018","unstructured":"Rizvi, S. A. & Saleh, A. M. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm. J.26 (1), 64\u201370 (2018).","journal-title":"Saudi Pharm. J."},{"key":"73105_CR83","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jconrel.2016.07.051","volume":"238","author":"A Banerjee","year":"2016","unstructured":"Banerjee, A., Qi, J., Gogoi, R., Wong, J. & Mitragotri, S. Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J. Controlled Release. 238, 176\u2013185 (2016).","journal-title":"J. Controlled Release"},{"issue":"2","key":"73105_CR84","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1208\/s12249-018-1276-9","volume":"20","author":"DL Roberts","year":"2019","unstructured":"Roberts, D. L. & Mitchell, J. P. Measurement of aerodynamic particle size distribution of orally inhaled products by cascade impactor: How to let the product specification drive the quality requirements of the cascade impactor. AAPS PharmSciTech. 20 (2), 57 (2019).","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"73105_CR85","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12906-022-03619-9","volume":"22","author":"F Esmaeili","year":"2022","unstructured":"Esmaeili, F. et al. Anti-inflammatory and anti-nociceptive effects of cinnamon and clove essential oils nanogels: An in vivo study. BMC Complement. Med. Ther.22 (1), 143 (2022).","journal-title":"BMC Complement. Med. Ther."},{"key":"73105_CR86","doi-asserted-by":"crossref","unstructured":"Manan, F. A. A. et al. Drug release profiles of Mitomycin C encapsulated quantum dots-chitosan nanocarrier system for the possible treatment of non-muscle invasive bladder cancer. Pharmaceutics; 13(9). (2021).","DOI":"10.3390\/pharmaceutics13091379"},{"issue":"4","key":"73105_CR87","doi-asserted-by":"publisher","first-page":"2000375","DOI":"10.1002\/mabi.202000375","volume":"21","author":"W Wei","year":"2021","unstructured":"Wei, W. et al. Chitosan nanoparticles loaded with truncated ORF2 protein as an oral vaccine candidate against hepatitis E. Macromol. Biosci.21 (4), 2000375 (2021).","journal-title":"Macromol. Biosci."},{"issue":"1","key":"73105_CR88","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/21645515.2019.1640427","volume":"16","author":"E Ndungo","year":"2020","unstructured":"Ndungo, E. & Pasetti, M. F. Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella. Hum. Vaccines Immunother.  16 (1), 197\u2013205 (2020).","journal-title":"Hum. Vaccines Immunother."},{"key":"73105_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-018-1439-1","volume":"16","author":"FR Toapanta","year":"2018","unstructured":"Toapanta, F. R., Bernal, P. J., Kotloff, K. L., Levine, M. M. & Sztein, M. B. T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. J. Transl. Med.16, 1\u201317 (2018).","journal-title":"J. Transl. Med."},{"issue":"3","key":"73105_CR90","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4049\/jimmunol.175.3.1735","volume":"175","author":"K Le-Barillec","year":"2005","unstructured":"Le-Barillec, K. et al. Roles for T and NK cells in the innate immune response to Shigella flexneri. J. Immunol.175 (3), 1735\u20131740 (2005).","journal-title":"J. Immunol."},{"issue":"5","key":"73105_CR91","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1128\/IAI.00939-10","volume":"79","author":"SP Jehl","year":"2011","unstructured":"Jehl, S. P. et al. Antigen-specific CD8\u2009+\u2009T cells fail to respond to Shigella flexneri. Infect. Immun.79 (5), 2021\u20132030 (2011).","journal-title":"Infect. Immun."},{"issue":"2","key":"73105_CR92","doi-asserted-by":"publisher","first-page":"29","DOI":"10.21315\/tlsr2021.32.2.3","volume":"32","author":"S Michael","year":"2021","unstructured":"Michael, S., Zakaria, N. M., Abbas, M. A., Abdullah, H. & Suppian, R. Immunomodulatory effects of asiaticoside against shigella flexneri-infected macrophages. Trop. life Sci. Res.32 (2), 29 (2021).","journal-title":"Trop. life Sci. Res."},{"issue":"4","key":"73105_CR93","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.coi.2006.05.002","volume":"18","author":"MB Lodoen","year":"2006","unstructured":"Lodoen, M. B. & Lanier, L. L. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol.18 (4), 391\u2013398 (2006).","journal-title":"Curr. Opin. Immunol."},{"issue":"8","key":"73105_CR94","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1128\/IAI.67.8.3970-3979.1999","volume":"67","author":"SS Way","year":"1999","unstructured":"Way, S. S., Borczuk, A. C. & Goldberg, M. B. Thymic independence of adaptive immunity to the intracellular pathogen Shigella flexneri serotype 2a. Infect. Immun.67 (8), 3970\u20133979 (1999).","journal-title":"Infect. Immun."},{"issue":"2","key":"73105_CR95","doi-asserted-by":"publisher","first-page":"281","DOI":"10.14202\/vetworld.2022.281-287","volume":"15","author":"K Anam","year":"2022","unstructured":"Anam, K. et al. Shigella flexneri vaccine development: oral administration of peptides derived from the 49.8\u00a0kDa pili protein subunit activates the intestinal immune response in mice. Vet. World. 15 (2), 281 (2022).","journal-title":"Vet. World"},{"issue":"23","key":"73105_CR96","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1016\/j.vaccine.2019.04.053","volume":"37","author":"B Yagnik","year":"2019","unstructured":"Yagnik, B., Sharma, D., Padh, H. & Desai, P. Oral immunization with LacVax\u00ae OmpA induces protective immune response against Shigella flexneri 2a ATCC 12022 in a murine model. Vaccine. 37 (23), 3097\u20133105 (2019).","journal-title":"Vaccine"},{"issue":"12","key":"73105_CR97","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1128\/IAI.00859-13","volume":"81","author":"FJ Martinez-Becerra","year":"2013","unstructured":"Martinez-Becerra, F. J. et al. Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a Pan-shigella vaccine. Infect. Immun.81 (12), 4470\u20134477 (2013).","journal-title":"Infect. Immun."},{"issue":"9","key":"73105_CR98","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.biomaterials.2012.11.066","volume":"34","author":"B Koppolu","year":"2013","unstructured":"Koppolu, B. & Zaharoff, D. A. The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells. Biomaterials.  34 (9), 2359\u20132369 (2013).","journal-title":"Biomaterials"},{"issue":"11","key":"73105_CR99","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/pharmaceutics11110612","volume":"11","author":"CG Kim","year":"2019","unstructured":"Kim, C. G., Kye, Y-C. & Yun, C-H. The role of nanovaccine in cross-presentation of antigen-presenting cells for the activation of CD8\u2009+\u2009T cell responses. Pharmaceutics. 11 (11), 612 (2019).","journal-title":"Pharmaceutics"},{"issue":"1","key":"73105_CR100","first-page":"1356540","volume":"2019","author":"A Thakur","year":"2019","unstructured":"Thakur, A., Mikkelsen, H. & Jungersen, G. Intracellular pathogens: host immunity and microbial persistence strategies. J. Immunol. Res.2019 (1), 1356540 (2019).","journal-title":"J. Immunol. Res."},{"issue":"5","key":"73105_CR101","doi-asserted-by":"publisher","first-page":"105100","DOI":"10.1016\/j.micinf.2023.105100","volume":"25","author":"U Bhaumik","year":"2023","unstructured":"Bhaumik, U. et al. A tetravalent Shigella outer membrane vesicles based candidate vaccine offered cross-protection against all the serogroups of Shigella in adult mice. Microbes Infect.25 (5), 105100 (2023).","journal-title":"Microbes Infect."},{"issue":"3","key":"73105_CR102","doi-asserted-by":"publisher","first-page":"e00019","DOI":"10.1128\/msphere.00019-23","volume":"8","author":"G Desalegn","year":"2023","unstructured":"Desalegn, G. et al. A novel Shigella O-polysaccharide\u2013IpaB conjugate vaccine elicits robust antibody responses and confers protection against multiple Shigella serotypes. Msphere. 8 (3), e00019\u201323 (2023).","journal-title":"Msphere"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73105-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73105-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73105-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T12:04:07Z","timestamp":1727525047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73105-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73105"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73105-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"11 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22484"}}